Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Tactics used x Hedge Fund & MM to acquire shareholder stock

<< Previous

Bullboard Posts

Next >>

Comment by Noteableon Dec 07, 2022 11:52am

110 Views

Post# 35156467

RE:RE:RE:RE:Tactics used x Hedge Fund & MM to acquire shareholder stock

SundayMovies aka "R" on the Yahoo message board is a prime example of one of those employed by a hedgefund to clutter a company message boards with garbage aka "sweet nothings".

And these same prime examples of a "barking dog" are quick to turn into rats once revealed.

<< Previous

Bullboard Posts

Next >>

Quest Diagnostics to acquire LifeLabs from OMERS for C$1.35 billion